Furthermore, the engagement of the HIF-1α/VEGF axis by estrogen- and endothelin-activated GPER signaling has been shown to stimulate angiogenesis and tumor growth both in vitro and in vivo, as evidenced in breast and hepatic cancer models as well as in CAFs [72,203]. The gene discussed is GPER1; the disease is neoplasm.